Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Intellipharmaceutics International Inc
V.IPCI.H
Alternate Symbol(s):
IPCIQ
Healthcare
Biotechnology
Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several...
drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company’s abuse-deterrent oxycodone hydrochloride extended-release formulation (Oxycodone ER) based on its proprietary nPODDDS novel Point of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules). Its product portfolio includes both new products and controlled-release generic products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:IPCI.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
Next
(3018)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Dec 22, 2021 7:08pm
Comments on Recent Trading Activity
TORONTO, ON / ACCESSWIRE / December 22, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical
...more
(19)
•••
whoknows
X
View Profile
View Bullboard History
Post by
whoknows
on Jul 06, 2021 3:34pm
Sold all my shares !
Good for me: i sold all my shares This company seems having no future. Dead place without news !
(19)
•••
whoknows
X
View Profile
View Bullboard History
Post by
whoknows
on May 05, 2021 12:36pm
Is IPCI a dying company ???????
Is IPCI a company with a stagnant market value? No news to stimulate the stock market! Has IPCI become an empty shell... no news
(105)
•••
Normandt1965
X
View Profile
View Bullboard History
Post by
Normandt1965
on Apr 25, 2021 8:44pm
ANDA
Dexmethylphenidate ER Metformin ER Venlafaxine ER Pantoprazole ER Quetiapine ER Lamotrigine ER Levetiracetam ER Desvenlafaxine ER Ranolazine ER Carvedilol ER Put that in your pipe
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on Apr 25, 2021 7:25pm
RE:Buyer beware!
They've been saying since last November that if they get enough money they'll be launching generic Seroquel XR®, generic Pristiq® and generic Effexor XR® and now with the
...more
(12)
•••
TrumpThis
X
View Profile
View Bullboard History
Post by
TrumpThis
on Apr 23, 2021 11:26am
Buyer beware!
I just sold my last 52 shares @ $0.28 of IPCI from holdings since the Vasogen days when IPCI took over Vasogen Oct22/2009 and they have done NOTHING, ZERO ever since and in the last two years, mgmt
...more
(189)
•••
biggerr
X
View Profile
View Bullboard History
Comment by
biggerr
on Apr 12, 2021 5:59pm
RE:Opioid (deterrent)
It looks like FDA after a year of doing nothing is beginning to move on opioids again. This Hysingla which it approved sounds very much like the Aximiris, so there is a hope that we'll be next now
...more
(105)
•••
Normandt1965
X
View Profile
View Bullboard History
Post by
Normandt1965
on Apr 02, 2021 10:08am
Opioid (deterrent)
2021 February: On February 1, the FDA provided an update on the pilot program with the National Telecommunications and Information Administration (NTIA) and three domain name registries to help reduce
...more
(32)
•••
AstonMartin13
X
View Profile
View Bullboard History
Comment by
AstonMartin13
on Feb 06, 2021 5:49pm
RE:RE:RE:RE:RE:UP 50%
I think that day is approaching really fast now.
(36)
•••
TankRebel2012
X
View Profile
View Bullboard History
Comment by
TankRebel2012
on Jun 23, 2020 11:28am
RE:RE:RE:RE:UP 50%
Only matter of time to hear what going on inside this company.... Invested a sleeper position because what this company holds is Solid ... one day will wake up in a very big way. For now we
...more
(959)
•••
Red_Deer
X
View Profile
View Bullboard History
Comment by
Red_Deer
on Jun 11, 2020 2:31pm
RE:RE:RE:UP 50%
(959)
•••
Red_Deer
X
View Profile
View Bullboard History
Comment by
Red_Deer
on Jun 10, 2020 1:06pm
RE:RE:UP 50%
THUMBs UP eh !!!!!!!!!!!!
(8210)
•••
TJPatrol1
X
View Profile
View Bullboard History
Comment by
TJPatrol1
on Jun 10, 2020 9:22am
RE:UP 50%
GLTA
(0)
•••
Priotoma
X
View Profile
View Bullboard History
Comment by
Priotoma
on Apr 17, 2020 1:35pm
RE:RE:RE:RE:RE:Pill deserved the no vote but it's an easy fix.
It's been 3 months since AdCom meeting and really unknown the reason behind not publishing the final result. Looks like FDA doesn't have answer to say NO to IPCI. on the other hand they
...more
(68)
•••
bigkagan
X
View Profile
View Bullboard History
Post by
bigkagan
on Apr 01, 2020 3:00pm
UP 50%
since Mar.23. Only 2 weeks left for FDA to decide. If pot stores are deemed essential why not also allow a safe oipiod like Aximiris to calm nerves in this tense period, hee
Prev
1
2
3
4
5
6
7
8
9
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
A potential breakthrough in spinal cord and optic nerve injury treatment
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Debt-Free Cannabis Company Set for Next Stage of Growth